(S)-2-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-6-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid

ID: ALA178421

Chembl Id: CHEMBL178421

PubChem CID: 3013755

Max Phase: Preclinical

Molecular Formula: C31H37N3O6S

Molecular Weight: 579.72

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)CN([C@@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O)S(=O)(=O)c1ccc(N)cc1

Standard InChI:  InChI=1S/C31H37N3O6S/c1-21(2)19-34(41(38,39)23-16-14-22(32)15-17-23)29(30(35)36)13-7-8-18-33-31(37)40-20-28-26-11-5-3-9-24(26)25-10-4-6-12-27(25)28/h3-6,9-12,14-17,21,28-29H,7-8,13,18-20,32H2,1-2H3,(H,33,37)(H,35,36)/t29-/m0/s1

Standard InChI Key:  WPMLSGGBESQETR-LJAQVGFWSA-N

Associated Targets(Human)

PGA5 Tclin Pepsin A (59 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 protease (9113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 579.72Molecular Weight (Monoisotopic): 579.2403AlogP: 5.08#Rotatable Bonds: 13
Polar Surface Area: 139.03Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.53CX Basic pKa: 2.29CX LogP: 4.73CX LogD: 1.59
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.19Np Likeness Score: -0.59

References

1. Bouzide A, Sauvé G, Yelle J..  (2005)  Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.,  15  (5): [PMID:15713418] [10.1016/j.bmcl.2004.12.068]

Source